Large Study Finds No Survival Benefit Associated With Removal Of Ovaries
ASCO Advises KRAS Testing In Patients With Metastatic Colorectal Cancer
Study Links Obesity To Higher Risk of Ovarian Cancer
Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line
Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity
Early HER2 Positive Patients At Higher Risk of Recurrence
Tykerb Plus Letrozole Delayed Metastatic Breast Cancer
Estrogen Can Benefit Women With Metastatic Breast Cancer
Alternating Mammography, MRI Tested For High-Risk Women
Degarelix Approved For Advanced Prostate Cancer
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- As Trump’s second term nears, Republican support for NIH is at a low point
By stonewalling GOP in the House, Biden’s HHS officials eroded bipartisan support for biomedical research - Cedars-Sinai spearheads first national certification program for COE staff at cancer centers
- Menin inhibitors emerge as new treatment for advanced AML
- Trump 2016: A look back at the 45th president’s impact on oncology
- Patient navigation benefits health systems, improves care
Initial data presented at the White House come a year after CMS payment began - Larry Einhorn reflects on his pioneering work on platinum-based chemotherapy at the AACI/CCAF annual meeting
